Equities

YiChang HEC ChangJiang Pharmaceutical Co Ltd

YiChang HEC ChangJiang Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)8.29
  • Today's Change0.10 / 1.22%
  • Shares traded2.14m
  • 1 Year change+20.14%
  • Beta1.0639
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income2,12739(667)
Depreciation/depletion172149100
Non-Cash items7881,143223
Cash taxes paid, supplemental230255(19)
Cash interest paid, supplemental139113100
Changes in working capital(1633)140(478)
Total cash from operations1,6731,700(663)
INVESTING
Capital expenditures(595)(853)(580)
Other investing and cash flow items, total1,150(267)141
Total cash from investing555(1120)(439)
FINANCING
Financing cash flow items(178)(151)(100)
Total cash dividends paid----0
Issuance (retirement) of stock, net----0
Issuance (retirement) of debt, net(1299)(636)287
Total cash from financing(1477)(787)187
NET CHANGE IN CASH
Foreign exchange effects(0.01)(0.3)0.29
Net change in cash751(208)(914)
Net cash-begin balance/reserved for future use9241,1312,045
Net cash-end balance/reserved for future use1,6749241,131
SUPPLEMENTAL INCOME
Depreciation, supplemental172149100
Cash interest paid, supplemental139113100
Cash taxes paid, supplemental230255(19)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.